Sat. Sep 26th, 2020

Market and Financial News Aggregator

The Federal Program That Keeps Insulin Prices High

1 min read

Perhaps the biggest flashpoint in the political debate about prescription drug prices is the cost of insulin. This summer an executive order from President Trump required low prices for some patients, and Eli Lilly last week announced new measures to make insulin more affordable for diabetics. Yet many aren’t aware that a federal program is goosing the price of insulin and other treatments, and keeping the prices high for patients who need these drugs.

Over the past few months the little-known 340B Drug Pricing Program has…

2020-09-10 19:10:00

Read more from source here…

Leave a Reply